中国全科医学2017，Vol.20Issue(18)：2294-2298,5.DOI:10.3969/j.issn.1007-9572.2017.04.y13
甲状腺相关性眼病的评估方法及激素治疗进展
Assessment Method of Thyroid Associated Ophthalmopathy and Its Steroid Treatment Process
摘要
Abstract
Thyroid associated ophthalmopathy(TAO) is an autoimmune eye disease that associated with thyroid disease.It often causes symptoms such as exophthalmos,eyelid retraction,eye swelling,and diplopia,and even affects the optic nerve,and seriously affects the quality of life of patients.With definite curative effect,glucocorticoid is the main treatment means of TAO.However,its therapeutic outcome is unsatisfactory in a considerable number of patients.Currently domestic and foreign scholars focus on the exploration of pathogenesis,severity assessment method and optimization of steroid treatment plan and the application of novel drugs and have achieved some progresses.The review on the above aspects in this paper aims to provide support for the individual selection of therapeutic programs of TAO,and provide clues for the research direction of optimization programs of the treatment of TAO.关键词
Graves眼病/甲状腺相关性眼病/糖皮质激素类Key words
Graves ophthalmopathy/Thyroid-associated ophthalmopathy/Glucocorticoids分类
医药卫生引用本文复制引用
屠晓芳,张洪梅..甲状腺相关性眼病的评估方法及激素治疗进展[J].中国全科医学,2017,20(18):2294-2298,5.基金项目
国家自然科学基金青年科学基金资助项目(81300642) （81300642）
